Clinical Trial Update: Methotrexate, Glucarpidase, and Leucovorin in Treating Patients With Newly Diagnosed Primary Central Nervous System Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating a combination of methotrexate, glucarpidase, and leucovorin in newly diagnosed primary central nervous system lymphoma; the study has…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Lymphoma

Drugs mentioned

• Glucarpidase (glucarpidase)
• Leucovorin (folinic acid)
• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: University College, London | Conditions: Chemotherapeutic Agent Toxicity, Lymphoma | Phase 1, Phase 2 | Status: COMPLETED